FDA — authorised 15 December 2016
- Application: NDA206977
- Marketing authorisation holder: IBSA
- Local brand name: TIROSINT-SOL
- Indication: SOLUTION — ORAL
- Status: approved
🇺🇸 Tirosint®-SOL in United States
FDA authorised Tirosint®-SOL on 15 December 2016
Marketing authorisation
Other Endocrinology approved in United States
Frequently asked questions
Is Tirosint®-SOL approved in United States?
Yes. FDA authorised it on 15 December 2016.
Who is the marketing authorisation holder for Tirosint®-SOL in United States?
IBSA holds the US marketing authorisation.